ERC1671

· Epitopoietic Research Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ERC1671, covering 2025-03-05 to 2025-03-05. Get the full timeline:

Most recent: Clinical Trial Update: ERC1671/GM-CSF/Cyclophosphamide for the Treatment of Glioblastoma Multiforme [Phase 2]